Clee Medical Advances to the Next Stage of the W.A. de Vigier Award 2025 🎉
We are excited to share that Clee Medical has been selected as one of the 15 startups advancing to the next stage of the prestigious W.A. de Vigier Award 2025!
The W.A. de Vigier Award is Switzerland’s longest-standing prize for young entrepreneurs, recognizing innovative startups that have the potential to make a significant impact in their industries. Being among the selected companies is a great honor and reinforces our mission to redefine neurosurgical care through AI-driven imaging solutions.
At Clee Medical, we are committed to enhancing surgical precision and patient safety by providing cutting-edge medical technology to healthcare professionals. Advancing in this competition brings us one step closer to gaining support, visibility, and mentorship to accelerate our growth.
We are proud to stand alongside other groundbreaking Swiss startups and look forward to the next steps in this journey.
A huge thank you to the W.A. de Vigier Foundation for this opportunity, and congratulations to all the other selected startups!
🔗 Read more about the selection:
Startupticker Article